New England Research & Management, Inc.

Position in MRNA — Moderna, Inc.

CIK 1596077 CHICAGO, IL

Position in MRNA

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$479,705

-$59,494 QoQ

Shares Held

6,850

+222.7% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

#381

of 772 holders

Holding Since

Dec 2020

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

New England Research & Management, Inc. holds $4,649,048 across 5 Biotechnology names. MRNA ranks #3 (10.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	3,475	$2,166,801
2	VRTX	Vertex Pharmaceuticals Inc / Ma	2,575	$1,279,079
3	MRNA	Moderna, Inc. This page	6,850	$479,705
4	INCY	Incyte Corp	3,575	$405,262
5	AXSM	Axsome Therapeutics, Inc.	1,300	$318,201

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$479,705	6,850	+222.7%	Shares	Sole	2026-07-09
2021-12-31	$539,199	2,123	-16.8%	Shares	Sole	2022-01-05
2021-09-30	$981,777	2,551	-5.5%	Shares	Sole	2021-10-08
2021-06-30	$634,446	2,700	+74.2%	Shares	Sole	2021-07-15
2021-03-31	$202,972	1,550	-72.6%	Shares	Sole	2021-04-16
2020-12-31	$590,255	5,650	—	Shares	Sole	2021-01-07
No filing history on record for this holder in this stock.